Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors
Clinical trial NCT06524024 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06524024
- Sponsor
- Zhengzhou Revo-Gene Technology Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2026-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.